Toxicology Research Today is a free monthly online journal that collates and summarizes the latest research about Toxicology, including details on forensic toxicology, carcinogenicity, assays.

Volume 3 (2007), Issue 8 (August)

1. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.
   Nat Rev Drug Discov, 6(8): 636-49. [Abstract] [Full-text]
2. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies.
   Am J Physiol Lung Cell Mol Physiol, 293(2): L272-8. [Abstract] [Full-text]
3. The risk of bankruptcy before and after brain or spinal cord injury: a glimpse of the iceberg's tip.
   Med Care, 45(8): 702-11. [Abstract] [Full-text]
4. Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments.
   Annu Rev Pharmacol Toxicol. [Abstract] [Full-text]
5. Toxicogenomics and ecotoxicogenomics for studying endocrine disruption and basic biology.
   Gen Comp Endocrinol, 153(1): 25-9. [Abstract] [Full-text]
6. A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters.
   Food Chem Toxicol, 45(9): 1551-7. [Abstract] [Full-text]
7. Current literature in mass spectrometry.
   J Mass Spectrom, 42(8): 1111-22. [Abstract] [Full-text]
8. Bias in toxicology.
   Arch Toxicol, 81(9): 605-17. [Abstract] [Full-text]
9. The use of metabolomics for the discovery of new biomarkers of effect.
   Toxicol Lett, 172(1): 21-8. [Abstract] [Full-text]
10. Inhalation toxicology of ricin preparations: animal models, prophylactic and therapeutic approaches to protection.
    Inhal Toxicol, 19(10): 873-87. [Abstract] [Full-text]
11. The health impact of common inorganic components of fine particulate matter (PM2.5) in ambient air: a critical review.
    Inhal Toxicol, 19(10): 811-32. [Abstract] [Full-text]
12. Reviewing the environmental and human health knowledge base of carbon nanotubes.
    Environ Health Perspect, 115(8): 1125-31. [Abstract] [Full-text]
13. Research approaches to address uncertainties in the risk assessment of arsenic in drinking water.
    Toxicol Appl Pharmacol, 222(3): 399-404. [Abstract] [Full-text]
14. Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction?
    Toxicol Appl Pharmacol, 222(3): 381-7. [Abstract] [Full-text]
15. Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh.
    Toxicol Appl Pharmacol, 222(3): 374-80. [Abstract] [Full-text]
16. Toward a checklist for exchange and interpretation of data from a toxicology study.
    Toxicol Sci, 99(1): 26-34. [Abstract] [Full-text]
17. A review of large granular lymphocytic leukemia in Fischer 344 rats as an initial step toward evaluating the implication of the endpoint to human cancer risk assessment.
    Toxicol Sci, 99(1): 3-19. [Abstract] [Full-text]
18. Predicting the toxic potential of drugs and chemicals in silico: a model for the peroxisome proliferator-activated receptor gamma (PPAR gamma).
    Toxicol Lett, 173(1): 17-23. [Abstract] [Full-text]
19. Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat.
    Toxicol Sci, 99(1): 58-69. [Abstract] [Full-text]
20. Genetic toxicity assessment: employing the best science for human safety evaluation Part VII: Why not start with a single test: a transformational alternative to genotoxicity hazard and risk assessment.
    Toxicol Sci, 99(1): 20-5. [Abstract] [Full-text]
21. Acute hepatotoxicity: a predictive model based on focused illumina microarrays.
    Toxicol Sci, 99(1): 289-302. [Abstract] [Full-text]
22. A validated SPME-GC-MS method for simultaneous quantification of club drugs in human urine.
    Forensic Sci Int, 171(2): 142-50. [Abstract] [Full-text]
23. Effect of ethanol on cardiac single sodium channel gating.
    Forensic Sci Int, 171(2): 131-5. [Abstract] [Full-text]
24. Estimating the uncertainty associated with Widmark's equation as commonly applied in forensic toxicology.
    Forensic Sci Int, 172(1): 33-9. [Abstract] [Full-text]
25. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
    Exp Clin Psychopharmacol, 15(4): 344-50. [Abstract] [Full-text]
26. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone.
    Eur J Gastroenterol Hepatol, 19(9): 741-7. [Abstract] [Full-text]
27. Novel and future applications of microarrays in toxicological research.
    Expert Opin Drug Metab Toxicol, 3(4): 599-608. [Abstract] [Full-text]
28. The relationship between alcohol elimination rate and increasing blood alcohol concentration--calculated from two consecutive blood specimens.
    Forensic Sci Int, 172(1): 28-32. [Abstract] [Full-text]
29. Markers of chronic alcohol use in hair: comparison of ethyl glucuronide and cocaethylene in cocaine users.
    Forensic Sci Int, 172(1): 23-7. [Abstract] [Full-text]
30. Analysis of the mouse liver proteome using advanced mass spectrometry.
    J Proteome Res, 6(8): 2963-72. [Abstract] [Full-text]
31. Regulation of branchial zinc uptake by 1alpha,25-(OH)(2)D(3) in rainbow trout and associated changes in expression of ZIP1 and ECaC.
    Aquat Toxicol, 84(2): 142-52. [Abstract] [Full-text]
32. Variability in the evaluation and management of opiate-exposed newborns in Maryland.
    Clin Pediatr (Phila), 46(7): 632-5. [Abstract] [Full-text]
33. Epigenetic transgenerational toxicology and germ cell disease.
    Int J Androl, 30(4): 393-7. [Abstract] [Full-text]
34. Nicotinic Acid: Pharmacological Effects and Mechanisms of Action.
    Annu Rev Pharmacol Toxicol. [Abstract] [Full-text]
35. Determinants of variability in acute to chronic toxicity ratios for aquatic invertebrates and fish.
    Environ Toxicol Chem, 26(9): 2019-23. [Abstract] [Full-text]
36. Combustion-derived nanoparticles: mechanisms of pulmonary toxicity.
    Clin Exp Pharmacol Physiol, 34(10): 1044-50. [Abstract] [Full-text]
37. Current literature in mass spectrometry.
    J Mass Spectrom, 42(9): 1251-1262. [Abstract] [Full-text]
38. A fatal doxepin poisoning associated with a defective CYP2D6 genotype.
    Am J Forensic Med Pathol, 28(3): 259-61. [Abstract] [Full-text]
39. The toxicology of cannabis and cannabis prohibition.
    Chem Biodivers, 4(8): 1744-69. [Abstract] [Full-text]
40. Primaquine-induced differential gene expression analysis in mice liver using DNA microarrays.
    Toxicology, 239(1): 96-107. [Abstract] [Full-text]
41. Simplified models to analyse time- and dose-dependent responses of populations to toxicants.
    Ecotoxicology, 16(7): 511-23. [Abstract] [Full-text]
42. Single-calibrant quantification of drugs in plasma and whole blood by liquid chromatography-chemiluminescence nitrogen detection.
    J Chromatogr B Analyt Technol Biomed Life Sci, 856(1): 239-44. [Abstract] [Full-text]
43. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs?
    Curr Opin Chem Biol, 11(4): 405-9. [Abstract] [Full-text]
44. Studies of the comparative in vitro toxicology of the cyanobacterial metabolite deoxycylindrospermopsin.
    J Toxicol Environ Health A, 70(19): 1679-86. [Abstract] [Full-text]
45. Issues in Australian contaminated land risk assessment toxicology.
    J Toxicol Environ Health A, 70(19): 1635-7. [Abstract] [Full-text]
46. Toxicology in Australia: a key component of environmental health.
    J Toxicol Environ Health A, 70(19): 1578-83. [Abstract] [Full-text]

© 2005-2008 Toxicology Research Today. All Rights Reserved.